IP-6

Volver al artículo.

Referencias para el artículo

  1. Graf E, Eaton JW. Antioxidant functions of phytic acid. Free Radic Biol Med 1990;8:61–9 [review].
  2. Shamsuddin AM, Vucenik I, Cole KE. IP-6: a novel anticancer agent. Life Sci 1997;61:343–54 [review].
  3. Graf E, Eaton JW. Suppression of colonic cancer by dietary phytic acid. Nutr Cancer 1993;19:11–9 [review].
  4. Vucenik I, Sakamoto K, Bansal M, et al. Inhibition of rat mammary carcinogenesis by inositol hexaphosphate (phytic acid). A pilot study. Cancer Lett 1993;75:95–102.
  5. Vucenik I, Yang G, Shamsuddin AM. Comparison of pure inositol hexaphosphate and high-bran diet in the prevention of DMBA-induced rat mammary carcinogenesis. Nutr Cancer 1997;28:7–13.
  6. Vucenik I, Yang G, Shamsuddin AM. Comparison of pure inositol hexaphosphate and high-bran diet in the prevention of DMBA-induced rat mammary carcinogenesis. Nutr Cancer 1997;28:7–13.
  7. Harland BF, Morris ER. Phytate: a good or a bad food component? Nutr Res 1995;15:733–54 [review].
  8. Owen RW, Weisgerber UM, Spiegelhalder B, et al. Faecal phytic acid and its relation to other putative markers of risk for colorectal cancer. Gut 1996;38:591–7.
  9. Vucenik I, Zhang ZS, Shamsuddin AM. IP6 in treatment of liver cancer II. Intra-tumoral injection of IP6 regresses pre-existing human liver cancer xenotransplanted in nude mice. Anticancer Res 1998;18:4091–6.
  10. Yoon JH, Thompson LU, Jenkins DJA. The effect of phytic acid on in vitro rate of starch digestibility and blood glucose response. Am J Clin Nutr 1983;38:835–42.
  11. Morris ER. Phytate and dietary mineral bioavailability. In Phytic Acid Chemistry and Applications, Graf E (ed). Minneapolis: Pilatus Press, 1986, 57–76 [review].
  12. Sandberg A-S, Brune M, Carlsson N-G, et al. Inositol phosphates with different numbers of phosphate groups influence iron absorption in humans. Am J Clin Nutr 1999;70:240–6.